| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | histone H2B deubiquitinase activity | 5.71e-06 | 4 | 20 | 2 | GO:0140936 | |
| GeneOntologyMolecularFunction | histone H2A deubiquitinase activity | 1.43e-05 | 6 | 20 | 2 | GO:0140950 | |
| GeneOntologyMolecularFunction | histone deubiquitinase activity | 2.66e-05 | 8 | 20 | 2 | GO:0140934 | |
| GeneOntologyMolecularFunction | RNA 7-methylguanosine cap binding | 8.61e-05 | 14 | 20 | 2 | GO:0000340 | |
| GeneOntologyMolecularFunction | RNA cap binding | 1.98e-04 | 21 | 20 | 2 | GO:0000339 | |
| GeneOntologyMolecularFunction | GTPase binding | 5.28e-03 | 360 | 20 | 3 | GO:0051020 | |
| GeneOntologyMolecularFunction | cysteine-type deubiquitinase activity | 5.74e-03 | 114 | 20 | 2 | GO:0004843 | |
| GeneOntologyMolecularFunction | deubiquitinase activity | 6.76e-03 | 124 | 20 | 2 | GO:0101005 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein peptidase activity | 8.19e-03 | 137 | 20 | 2 | GO:0019783 | |
| GeneOntologyBiologicalProcess | regulation of protein polymerization | 2.97e-06 | 231 | 21 | 5 | GO:0032271 | |
| GeneOntologyBiologicalProcess | positive regulation of lamellipodium assembly | 4.43e-06 | 32 | 21 | 3 | GO:0010592 | |
| GeneOntologyBiologicalProcess | regulation of protein-containing complex assembly | 6.90e-06 | 489 | 21 | 6 | GO:0043254 | |
| GeneOntologyBiologicalProcess | positive regulation of lamellipodium organization | 8.77e-06 | 40 | 21 | 3 | GO:1902745 | |
| GeneOntologyBiologicalProcess | regulation of lamellipodium assembly | 1.26e-05 | 45 | 21 | 3 | GO:0010591 | |
| GeneOntologyBiologicalProcess | protein polymerization | 1.78e-05 | 334 | 21 | 5 | GO:0051258 | |
| GeneOntologyBiologicalProcess | regulation of lamellipodium organization | 2.57e-05 | 57 | 21 | 3 | GO:1902743 | |
| GeneOntologyBiologicalProcess | positive regulation of neurotrophin TRK receptor signaling pathway | 2.75e-05 | 8 | 21 | 2 | GO:0051388 | |
| GeneOntologyBiologicalProcess | lamellipodium assembly | 6.84e-05 | 79 | 21 | 3 | GO:0030032 | |
| GeneOntologyBiologicalProcess | regulation of neurotrophin TRK receptor signaling pathway | 1.33e-04 | 17 | 21 | 2 | GO:0051386 | |
| GeneOntologyBiologicalProcess | lamellipodium organization | 1.34e-04 | 99 | 21 | 3 | GO:0097581 | |
| GeneOntologyBiologicalProcess | positive regulation of plasma membrane bounded cell projection assembly | 2.54e-04 | 123 | 21 | 3 | GO:0120034 | |
| GeneOntologyBiologicalProcess | neurotrophin TRK receptor signaling pathway | 5.43e-04 | 34 | 21 | 2 | GO:0048011 | |
| GeneOntologyBiologicalProcess | regulation of supramolecular fiber organization | 9.01e-04 | 438 | 21 | 4 | GO:1902903 | |
| GeneOntologyBiologicalProcess | regulation of cellular component biogenesis | 9.29e-04 | 1189 | 21 | 6 | GO:0044087 | |
| GeneOntologyBiologicalProcess | dendrite extension | 9.95e-04 | 46 | 21 | 2 | GO:0097484 | |
| GeneOntologyBiologicalProcess | neurotrophin signaling pathway | 1.04e-03 | 47 | 21 | 2 | GO:0038179 | |
| GeneOntologyCellularComponent | dendritic growth cone | 5.71e-05 | 12 | 20 | 2 | GO:0044294 | |
| GeneOntologyCellularComponent | SCAR complex | 5.71e-05 | 12 | 20 | 2 | GO:0031209 | |
| GeneOntologyCellularComponent | lateral plasma membrane | 8.34e-05 | 90 | 20 | 3 | GO:0016328 | |
| GeneOntologyCellularComponent | dendrite terminus | 1.64e-04 | 20 | 20 | 2 | GO:0044292 | |
| GeneOntologyCellularComponent | axonal growth cone | 8.40e-04 | 45 | 20 | 2 | GO:0044295 | |
| Domain | Cytoplasmic_FMR1-int | 1.09e-06 | 2 | 20 | 2 | IPR008081 | |
| Domain | FragX_IP | 1.09e-06 | 2 | 20 | 2 | PF05994 | |
| Domain | DUF1394 | 6.53e-06 | 4 | 20 | 2 | PF07159 | |
| Domain | DUF1394 | 6.53e-06 | 4 | 20 | 2 | IPR009828 | |
| Domain | zf-UBP | 9.84e-05 | 14 | 20 | 2 | PF02148 | |
| Domain | ZF_UBP | 9.84e-05 | 14 | 20 | 2 | PS50271 | |
| Domain | Znf_UBP | 9.84e-05 | 14 | 20 | 2 | IPR001607 | |
| Domain | USP_CS | 2.24e-03 | 66 | 20 | 2 | IPR018200 | |
| Domain | USP_1 | 2.52e-03 | 70 | 20 | 2 | PS00972 | |
| Domain | UCH | 2.59e-03 | 71 | 20 | 2 | PF00443 | |
| Domain | USP_2 | 2.59e-03 | 71 | 20 | 2 | PS00973 | |
| Domain | USP_dom | 2.66e-03 | 72 | 20 | 2 | IPR028889 | |
| Domain | Peptidase_C19_UCH | 2.66e-03 | 72 | 20 | 2 | IPR001394 | |
| Domain | USP_3 | 2.66e-03 | 72 | 20 | 2 | PS50235 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 2.08e-05 | 175 | 14 | 4 | MM15599 | |
| Pathway | REACTOME_RAC1_GTPASE_CYCLE | 2.54e-05 | 184 | 14 | 4 | M41809 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | 4.54e-05 | 439 | 14 | 5 | MM15595 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | 5.11e-05 | 450 | 14 | 5 | M27078 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 1.30e-04 | 103 | 14 | 3 | MM14752 | |
| Pathway | REACTOME_SIGNALING_BY_VEGF | 1.42e-04 | 106 | 14 | 3 | M27077 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPE_TO_RAC_SIGNALING_PATHWAY | 1.72e-04 | 20 | 14 | 2 | M47737 | |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | 1.76e-04 | 114 | 14 | 3 | MM14814 | |
| Pathway | KEGG_MEDICUS_REFERENCE_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY | 2.71e-04 | 25 | 14 | 2 | M47716 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | 2.88e-04 | 649 | 14 | 5 | MM15690 | |
| Pathway | REACTOME_FCGAMMA_RECEPTOR_FCGR_DEPENDENT_PHAGOCYTOSIS | 3.43e-04 | 143 | 14 | 3 | M27107 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SHIGELLA_IPGD_TO_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY | 3.66e-04 | 29 | 14 | 2 | M47717 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_SALMONELLA_SOPB_TO_ARNO_ARF_ACTB_G_SIGNALING_PATHWAY | 3.92e-04 | 30 | 14 | 2 | M47738 | |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | 4.66e-04 | 720 | 14 | 5 | M41838 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_WASPS_AND_WAVES | 5.05e-04 | 34 | 14 | 2 | MM15265 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_WASPS_AND_WAVES | 5.66e-04 | 36 | 14 | 2 | M27549 | |
| Pathway | REACTOME_LEISHMANIA_INFECTION | 1.19e-03 | 219 | 14 | 3 | M29836 | |
| Pathway | REACTOME_RHOJ_GTPASE_CYCLE | 1.32e-03 | 55 | 14 | 2 | M41815 | |
| Pathway | REACTOME_AURKA_ACTIVATION_BY_TPX2 | 2.19e-03 | 71 | 14 | 2 | MM15495 | |
| Pathway | REACTOME_RHOG_GTPASE_CYCLE | 2.19e-03 | 71 | 14 | 2 | MM15604 | |
| Pathway | REACTOME_AURKA_ACTIVATION_BY_TPX2 | 2.25e-03 | 72 | 14 | 2 | M27749 | |
| Pathway | REACTOME_RHOG_GTPASE_CYCLE | 2.37e-03 | 74 | 14 | 2 | M41814 | |
| Pathway | REACTOME_RECRUITMENT_OF_MITOTIC_CENTROSOME_PROTEINS_AND_COMPLEXES | 2.84e-03 | 81 | 14 | 2 | M748 | |
| Pathway | REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION | 3.12e-03 | 85 | 14 | 2 | MM14906 | |
| Pathway | REACTOME_REGULATION_OF_PLK1_ACTIVITY_AT_G2_M_TRANSITION | 3.27e-03 | 87 | 14 | 2 | M27194 | |
| Pathway | REACTOME_RAC2_GTPASE_CYCLE | 3.27e-03 | 87 | 14 | 2 | MM15600 | |
| Pathway | REACTOME_RAC2_GTPASE_CYCLE | 3.34e-03 | 88 | 14 | 2 | M41810 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 3.49e-03 | 90 | 14 | 2 | MM14979 | |
| Pathway | REACTOME_INNATE_IMMUNE_SYSTEM | 3.53e-03 | 1128 | 14 | 5 | M1036 | |
| Pathway | REACTOME_RAC3_GTPASE_CYCLE | 3.72e-03 | 93 | 14 | 2 | MM15609 | |
| Pathway | REACTOME_RAC3_GTPASE_CYCLE | 3.80e-03 | 94 | 14 | 2 | M41818 | |
| Pathway | REACTOME_RECRUITMENT_OF_NUMA_TO_MITOTIC_CENTROSOMES | 3.88e-03 | 95 | 14 | 2 | M6729 | |
| Pathway | REACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE | 3.96e-03 | 96 | 14 | 2 | MM15207 | |
| Pathway | REACTOME_ANCHORING_OF_THE_BASAL_BODY_TO_THE_PLASMA_MEMBRANE | 4.04e-03 | 97 | 14 | 2 | M27478 | |
| Pubmed | Different dysregulations of CYFIP1 and CYFIP2 in distinct types of dementia. | 3.47e-07 | 2 | 21 | 2 | 38128786 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 34327661 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 35203285 | ||
| Pubmed | Is co-expression of USP22 and HSP90 more effective in predicting prognosis of gastric cancer? | 3.47e-07 | 2 | 21 | 2 | 30598339 | |
| Pubmed | C57BL/6N mutation in cytoplasmic FMRP interacting protein 2 regulates cocaine response. | 3.47e-07 | 2 | 21 | 2 | 24357318 | |
| Pubmed | Cytoplasmic FMRP interacting protein 1/2 (CYFIP1/2) expression analysis in autism. | 3.47e-07 | 2 | 21 | 2 | 29752658 | |
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 35567753 | ||
| Pubmed | 3.47e-07 | 2 | 21 | 2 | 31324746 | ||
| Pubmed | 1.04e-06 | 3 | 21 | 2 | 34954996 | ||
| Pubmed | 2.08e-06 | 4 | 21 | 2 | 15294869 | ||
| Pubmed | 2.08e-06 | 4 | 21 | 2 | 27605705 | ||
| Pubmed | 2.08e-06 | 4 | 21 | 2 | 20228810 | ||
| Pubmed | 4.40e-06 | 421 | 21 | 5 | 36976175 | ||
| Pubmed | Differential cell-type-expression of CYFIP1 and CYFIP2 in the adult mouse hippocampus. | 5.20e-06 | 6 | 21 | 2 | 31853374 | |
| Pubmed | 5.20e-06 | 6 | 21 | 2 | 11438699 | ||
| Pubmed | 7.28e-06 | 7 | 21 | 2 | 30687000 | ||
| Pubmed | 9.27e-06 | 68 | 21 | 3 | 14676191 | ||
| Pubmed | 1.25e-05 | 9 | 21 | 2 | 22542455 | ||
| Pubmed | 1.25e-05 | 9 | 21 | 2 | 38981622 | ||
| Pubmed | 1.56e-05 | 10 | 21 | 2 | 31231033 | ||
| Pubmed | Abi1 is essential for the formation and activation of a WAVE2 signalling complex. | 1.56e-05 | 10 | 21 | 2 | 15048123 | |
| Pubmed | USP18 recruits USP20 to promote innate antiviral response through deubiquitinating STING/MITA. | 2.28e-05 | 12 | 21 | 2 | 27801882 | |
| Pubmed | 2.70e-05 | 13 | 21 | 2 | 34508581 | ||
| Pubmed | 5.28e-05 | 18 | 21 | 2 | 9463375 | ||
| Pubmed | 5.35e-05 | 708 | 21 | 5 | 39231216 | ||
| Pubmed | 6.03e-05 | 127 | 21 | 3 | 30442766 | ||
| Pubmed | 7.96e-05 | 22 | 21 | 2 | 35640597 | ||
| Pubmed | NYAP: a phosphoprotein family that links PI3K to WAVE1 signalling in neurons. | 7.96e-05 | 22 | 21 | 2 | 21946561 | |
| Pubmed | 1.81e-04 | 33 | 21 | 2 | 27803151 | ||
| Pubmed | 1.84e-04 | 484 | 21 | 4 | 31995728 | ||
| Pubmed | α-catenin interaction with YAP/FoxM1/TEAD-induced CEP55 supports liver cancer cell migration. | 2.04e-04 | 35 | 21 | 2 | 37381005 | |
| Pubmed | 3.20e-04 | 560 | 21 | 4 | 35241646 | ||
| Pubmed | 3.24e-04 | 44 | 21 | 2 | 31273033 | ||
| Pubmed | 3.31e-04 | 565 | 21 | 4 | 20458337 | ||
| Pubmed | 3.36e-04 | 1049 | 21 | 5 | 27880917 | ||
| Interaction | ZNF511 interactions | 8.70e-06 | 41 | 20 | 3 | int:ZNF511 | |
| Interaction | AMZ1 interactions | 1.08e-05 | 44 | 20 | 3 | int:AMZ1 | |
| Interaction | LETM2 interactions | 1.96e-05 | 7 | 20 | 2 | int:LETM2 | |
| Interaction | KCTD8 interactions | 2.61e-05 | 8 | 20 | 2 | int:KCTD8 | |
| Interaction | C4A interactions | 4.77e-05 | 72 | 20 | 3 | int:C4A | |
| Interaction | EPHA2 interactions | 5.10e-05 | 719 | 20 | 6 | int:EPHA2 | |
| Interaction | LYN interactions | 5.14e-05 | 720 | 20 | 6 | int:LYN | |
| Interaction | NYAP1 interactions | 7.25e-05 | 13 | 20 | 2 | int:NYAP1 | |
| Interaction | DLGAP4 interactions | 7.57e-05 | 84 | 20 | 3 | int:DLGAP4 | |
| Interaction | MYO16 interactions | 1.11e-04 | 16 | 20 | 2 | int:MYO16 | |
| Interaction | CGB2 interactions | 1.42e-04 | 18 | 20 | 2 | int:CGB2 | |
| Interaction | EPHA7 interactions | 1.52e-04 | 282 | 20 | 4 | int:EPHA7 | |
| Interaction | NCKAP1L interactions | 1.76e-04 | 20 | 20 | 2 | int:NCKAP1L | |
| Interaction | NHSL3 interactions | 1.83e-04 | 113 | 20 | 3 | int:NHSL3 | |
| Interaction | GJA1 interactions | 2.15e-04 | 583 | 20 | 5 | int:GJA1 | |
| Interaction | C11orf52 interactions | 2.22e-04 | 311 | 20 | 4 | int:C11orf52 | |
| Interaction | PRKCG interactions | 2.23e-04 | 121 | 20 | 3 | int:PRKCG | |
| Interaction | NYAP2 interactions | 2.34e-04 | 23 | 20 | 2 | int:NYAP2 | |
| Interaction | NPHP1 interactions | 2.76e-04 | 130 | 20 | 3 | int:NPHP1 | |
| Interaction | RAC3 interactions | 2.84e-04 | 619 | 20 | 5 | int:RAC3 | |
| Interaction | RHOJ interactions | 3.15e-04 | 633 | 20 | 5 | int:RHOJ | |
| Interaction | LCTL interactions | 3.24e-04 | 27 | 20 | 2 | int:LCTL | |
| Interaction | LAMP1 interactions | 3.41e-04 | 644 | 20 | 5 | int:LAMP1 | |
| Interaction | USP31 interactions | 3.48e-04 | 28 | 20 | 2 | int:USP31 | |
| Interaction | WASF2 interactions | 3.88e-04 | 146 | 20 | 3 | int:WASF2 | |
| Interaction | RHOF interactions | 4.18e-04 | 673 | 20 | 5 | int:RHOF | |
| Interaction | RAC2 interactions | 4.21e-04 | 674 | 20 | 5 | int:RAC2 | |
| Interaction | RPS6KC1 interactions | 4.28e-04 | 31 | 20 | 2 | int:RPS6KC1 | |
| Interaction | FASN interactions | 4.32e-04 | 1062 | 20 | 6 | int:FASN | |
| Interaction | RAC1 interactions | 4.34e-04 | 1063 | 20 | 6 | int:RAC1 | |
| Interaction | YES1 interactions | 4.51e-04 | 375 | 20 | 4 | int:YES1 | |
| Interaction | TNIK interactions | 4.79e-04 | 381 | 20 | 4 | int:TNIK | |
| Interaction | NRAS interactions | 4.97e-04 | 699 | 20 | 5 | int:NRAS | |
| Interaction | DCLK2 interactions | 5.15e-04 | 34 | 20 | 2 | int:DCLK2 | |
| Interaction | HRAS interactions | 5.87e-04 | 725 | 20 | 5 | int:HRAS | |
| Interaction | TMEM17 interactions | 5.98e-04 | 404 | 20 | 4 | int:TMEM17 | |
| Interaction | FKBPL interactions | 6.10e-04 | 37 | 20 | 2 | int:FKBPL | |
| Interaction | SPTBN2 interactions | 6.26e-04 | 172 | 20 | 3 | int:SPTBN2 | |
| Interaction | SIRT1 interactions | 6.43e-04 | 412 | 20 | 4 | int:SIRT1 | |
| Interaction | GAS7 interactions | 6.44e-04 | 38 | 20 | 2 | int:GAS7 | |
| Interaction | NTRK2 interactions | 6.69e-04 | 176 | 20 | 3 | int:NTRK2 | |
| Interaction | SPTBN1 interactions | 6.98e-04 | 421 | 20 | 4 | int:SPTBN1 | |
| Interaction | CAMK2B interactions | 7.38e-04 | 182 | 20 | 3 | int:CAMK2B | |
| Interaction | SHANK1 interactions | 7.50e-04 | 41 | 20 | 2 | int:SHANK1 | |
| Interaction | SERPING1 interactions | 7.87e-04 | 42 | 20 | 2 | int:SERPING1 | |
| Interaction | EPHA4 interactions | 8.10e-04 | 188 | 20 | 3 | int:EPHA4 | |
| Interaction | RND2 interactions | 8.23e-04 | 440 | 20 | 4 | int:RND2 | |
| Interaction | MATK interactions | 8.25e-04 | 43 | 20 | 2 | int:MATK | |
| Interaction | RHOQ interactions | 8.37e-04 | 442 | 20 | 4 | int:RHOQ | |
| Interaction | KLHL23 interactions | 8.63e-04 | 44 | 20 | 2 | int:KLHL23 | |
| Interaction | CFB interactions | 8.63e-04 | 44 | 20 | 2 | int:CFB | |
| Interaction | APBB1 interactions | 9.01e-04 | 195 | 20 | 3 | int:APBB1 | |
| Interaction | RPS6KA2 interactions | 9.14e-04 | 196 | 20 | 3 | int:RPS6KA2 | |
| Interaction | LRP1 interactions | 9.14e-04 | 196 | 20 | 3 | int:LRP1 | |
| Interaction | PRKX interactions | 9.43e-04 | 46 | 20 | 2 | int:PRKX | |
| Interaction | GUCY1B1 interactions | 9.85e-04 | 47 | 20 | 2 | int:GUCY1B1 | |
| GeneFamily | Ubiquitin specific peptidases | 8.37e-04 | 56 | 14 | 2 | 366 | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.05e-06 | 198 | 21 | 4 | 93cc01d91ffc543fd1a717ef47e02e532b50b665 | |
| ToppCell | facs-Brain_Myeloid-Cerebellum-24m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.60e-05 | 160 | 21 | 3 | 1f7acdc8b08152d5817fc53bbf47b4a22d9c91b5 | |
| ToppCell | facs-Brain_Myeloid-Hippocampus-24m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.14e-05 | 165 | 21 | 3 | ab6ed7e30096c418e7be2d5eec33feeddd1387d9 | |
| ToppCell | (1)_Control_(PBS)-(2)_LEPR+_perivascular_cells_and_VE-Cad+_vascular_cells_(mixed)|(1)_Control_(PBS) / Stress and Cell class | 7.56e-05 | 177 | 21 | 3 | d9e5ac5b8949a77e88e8094079167e4cf2c1bbd1 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-Treg_cell_2|368C / Donor, Lineage, Cell class and subclass (all cells) | 7.94e-05 | 180 | 21 | 3 | 551b8de8d933d11bcd3897aeb2fd033355f958e2 | |
| ToppCell | droplet-Kidney-nan-18m-Epithelial-kidney_loop_of_Henle_ascending_limb_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.34e-05 | 183 | 21 | 3 | 03c7e69136d5a3b9c5b2c91733e9b1c791f45c49 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-B|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 8.34e-05 | 183 | 21 | 3 | 62f76907e501bba6e1010b5c447faed5f0ef93a7 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_airway-epi_intermediate_(1)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.32e-05 | 190 | 21 | 3 | c95032bb3ee2b3d40fdf48016acb46d6f78a48a6 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_proliferating-epi_proliferating2_(13)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.62e-05 | 192 | 21 | 3 | 25378b5e4b0cea8415ff125783511fc25a56fc00 | |
| ToppCell | PCW_07-8.5-Epithelial-Epithelial_neuroendo-epi_NE_progenitor_(7)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 9.62e-05 | 192 | 21 | 3 | b99f8236ef4ccdc75c02abea381cae6453205f6f | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.62e-05 | 192 | 21 | 3 | 69758a256386a6ed3a6e2c94c55d59baa34892d7 | |
| ToppCell | COVID-19-kidney-Myeloid|COVID-19 / Disease (COVID-19 only), tissue and cell type | 9.62e-05 | 192 | 21 | 3 | 0b9d22a222f1201e375f8e55cace9ef939febae4 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-BDM-TAM-BDM_anti-infl-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.76e-05 | 193 | 21 | 3 | b52d5661edff83ac4c5fe2bf89d6672016bb827b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-E|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.76e-05 | 193 | 21 | 3 | 697518bab1338dc441b2d93b410d957e692f20e6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.01e-04 | 195 | 21 | 3 | b6bf75669f267ecdc96818c7022db852e37a9fe1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.02e-04 | 196 | 21 | 3 | e54c08f88779f9fd453a4f5b85aed1f460d8a1e1 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.05e-04 | 198 | 21 | 3 | 00a54af5267bfe0eeab6720bf890dc4b6b803bfd | |
| ToppCell | 3'-Parenchyma_lung-Immune_Myeloid-Myeloid_macrophage-alveolar_macrophage-Alveolar_macrophages-Alveolar_macrophages_L.1.6.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.07e-04 | 199 | 21 | 3 | 5b6feacb0ca92c3fc6b327be978320426dcf6f68 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig-F|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.07e-04 | 199 | 21 | 3 | b0a906586e58009f5ed9272fc29ba28e49c85ee6 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.07e-04 | 199 | 21 | 3 | e7faf7d0cb43cf93149c446e5f718f84fa85477c | |
| ToppCell | Hematolymphoid-Microglia-TYROBP--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.08e-04 | 200 | 21 | 3 | dc344b3ec51d506952e38f0b3a7795d65f9dd4eb | |
| ToppCell | Hematolymphoid-Microglia-TYROBP---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.08e-04 | 200 | 21 | 3 | a8646d0fca99f10827c2d2a12e584660ef7155f1 | |
| ToppCell | Hematolymphoid-Microglia|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.08e-04 | 200 | 21 | 3 | 21bcca3b670fe9bac034aef2275d3de4a9a73e2b | |
| ToppCell | Hematolymphoid-Microglia-TYROBP-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.08e-04 | 200 | 21 | 3 | 3bba5219453322198e8fdb0921d5f8c403598751 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.08e-04 | 200 | 21 | 3 | 33036d21c1c82109284473a515c4f890b33fdd5c | |
| ToppCell | Hematolymphoid-Microglia-TYROBP----L1-3|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 1.08e-04 | 200 | 21 | 3 | a20dce14f94777687aad57d6fbe3258ad376f63f | |
| ToppCell | Tracheal-NucSeq-Immune_Lymphocytic-T-T_CD8-CD8_CTL|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 1.08e-04 | 200 | 21 | 3 | 893bb7c25ad7c6589a4c7c0364c2ace666e9b4be | |
| ToppCell | 343B-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_0|CD8+_Cytotoxic_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 1.19e-03 | 109 | 21 | 2 | cc43c221487a712546917cc3253c158a1fc1fd7a | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-Differentiating_AT1|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.68e-03 | 130 | 21 | 2 | 6434d9106ccb38786dad36fab80163dfc07b6eb7 | |
| ToppCell | NS-moderate-d_07-13-Epithelial-IRC-IFNG_responsive_cell|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 1.83e-03 | 136 | 21 | 2 | 7f1ca43e0d164b511120316d4218d80ba21a9b5c | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_I-Z|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.08e-03 | 145 | 21 | 2 | 9743d68ba8bfef56fd9a979ab357c0e287eb5ae2 | |
| ToppCell | lung-Type_II_Pneumocytes|lung / shred on tissue and cell subclass | 2.14e-03 | 147 | 21 | 2 | 8a3039de45b8087f8319e2e37329acf7278219b7 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-F-|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.20e-03 | 149 | 21 | 2 | 9286bc56ff2e245630537a0bda5f1a1e17be863a | |
| ToppCell | droplet-Lung-18m-Hematologic-lymphocytic-CD8-positive,_alpha-beta_T_cell-CD8-positive,_alpha-beta_T_cell_l21|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.20e-03 | 149 | 21 | 2 | 65778f19599b4955c0a16f0121237656449431fb | |
| ToppCell | Leuk-UTI-Lymphocyte-T_NK-dnT|Leuk-UTI / Disease, Lineage and Cell Type | 2.20e-03 | 149 | 21 | 2 | 53f145cf7089d948d41aa3c443e983e011826836 | |
| ToppCell | 368C-Fibroblasts-Fibroblast-F|Fibroblasts / Donor, Lineage, Cell class and subclass (all cells) | 2.20e-03 | 149 | 21 | 2 | f53151d9e5e724a61be0ee6a8c740d1990f28d5f | |
| ToppCell | droplet-Kidney-nan-24m-Lymphocytic-CD45____macrophage|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.22e-03 | 150 | 21 | 2 | 34774b015adecc2be56a471fda8994e89a6ad93e | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_aging_sig|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.25e-03 | 151 | 21 | 2 | 2f9b3e14c2fa6e2b1976ca6ab2031b63bf5e3e64 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-03 | 153 | 21 | 2 | f6ef14d949107c08cb3690e26ec91e194cb43518 | |
| ToppCell | droplet-Lung-nan-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.31e-03 | 153 | 21 | 2 | 6dcab3d50ab50051955204dc4e4a64c1ca855bcd | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Conventional_Leiomyosarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 2.31e-03 | 153 | 21 | 2 | ec6fe6b8c884fa76adc7a0f9db041f7b1567a2ee | |
| ToppCell | IIH-Treg|IIH / Condition, Cell_class and T cell subcluster | 2.31e-03 | 153 | 21 | 2 | 17704e18833812fcf2a2727b1e3f8a9984ba5b59 | |
| ToppCell | facs-Brain_Myeloid-Cortex-24m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-03 | 154 | 21 | 2 | 1e088b0d4a44267f46a9b643f46a1aba784686b1 | |
| ToppCell | IIH-Treg-CD4_Treg|IIH / Condition, Cell_class and T cell subcluster | 2.34e-03 | 154 | 21 | 2 | d2211a892654b92decb208969040920f7ae8ba1e | |
| ToppCell | LPS-IL1RA+antiTNF-Myeloid-Monocytes,_Macrophages-Erythroid|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.37e-03 | 155 | 21 | 2 | 4559e3011514041b65c17ae4ede29da202bce14c | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage-macrophage,_alveolar|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.40e-03 | 156 | 21 | 2 | e0aef6104be16b12304b8e30358f444c1660e92f | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Myeloid-Macrophage|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.40e-03 | 156 | 21 | 2 | 5b2781d38a83b4b0f8a53cf321ce5db3a07d0818 | |
| ToppCell | PND07-28-samps-Myeloid-Granulocyte|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.40e-03 | 156 | 21 | 2 | 5e1c5a7c9293b886920739cf766521df7f69726c | |
| ToppCell | PND07-28-samps-Myeloid-Granulocyte-neutrophil__Lgals3-negative|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 2.40e-03 | 156 | 21 | 2 | 166f7b1220eaf8e1149dde260dd85a094855c54f | |
| ToppCell | 5'-Adult-SmallIntestine-Hematopoietic-T_cells-Treg|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.43e-03 | 157 | 21 | 2 | 2c767c526abcc8adea6ec4eb2cc333060bb213b5 | |
| ToppCell | droplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Endothelial-endocardial_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-03 | 157 | 21 | 2 | a426c54fd1545093d41426e9620862f71bd06f6b | |
| ToppCell | facs-Brain_Myeloid-Striatum_-18m-Myeloid-macrophage|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.43e-03 | 157 | 21 | 2 | 9d4308312301cb922f156a7b6aededc9e1c62807 | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)-myeloid-myeloid_macrophage-microglial_cell|tissue-resident_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.43e-03 | 157 | 21 | 2 | d4908cafd8870c1c225817f589ea2bce116ac7ab | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.46e-03 | 158 | 21 | 2 | 121d63b8e2e37107467b170e5b2c798a7dbf6325 | |
| ToppCell | 343B-Myeloid-Macrophage-SPP1+_Macrophage|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 2.46e-03 | 158 | 21 | 2 | de65af8d3b8514b17978155f31975e2347b75251 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-AM|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.49e-03 | 159 | 21 | 2 | 0c2437da5443fc3aff66f8ef311f02aa434a1fb0 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_macrophage-microglial_cell|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.49e-03 | 159 | 21 | 2 | 31ec8222c766cb614e1cf27f74ee9d99489eca5c | |
| ToppCell | 343B-Myeloid-Mast_cell-|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.52e-03 | 160 | 21 | 2 | a2f09b5955602819c8978f4372130c8ef915cd07 | |
| ToppCell | 343B-Myeloid-Mast_cell|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.52e-03 | 160 | 21 | 2 | 133ecae0a894d9a0d49d58859623359096b6f030 | |
| ToppCell | facs-Lung-18m-Hematologic-myeloid-non-classical_monocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.52e-03 | 160 | 21 | 2 | bc4a93dc5f37829799c37877e751ff3bc122e4ab | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell-kidney_loop_of_Henle_thick_ascending_limb_epithelial_cell-Medullary_Thick_Ascending_Limb_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-03 | 160 | 21 | 2 | 03b88dc7ad41c6ae443cab7e77ec666340bf432e | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-03 | 160 | 21 | 2 | 2020b6defbaf5b5db12af37f0103ac028a8ca76e | |
| ToppCell | renal_medulla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Cortical_Collecting_Duct_Intercalated_Cell_Type_A|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-03 | 160 | 21 | 2 | 1e210e526ea4d84fc58a798a26c0929bcb69fd89 | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.52e-03 | 160 | 21 | 2 | af7cf0dc5fe7c02f7d6c436f6dde766c79ff0eae | |
| ToppCell | facs-Lung-EPCAM-3m-Endothelial-Capillary_Type_1_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.56e-03 | 161 | 21 | 2 | a7e74bc80ac11250e353e5614b19c05793fc2e95 | |
| ToppCell | PBMC_fresh-frozen-Mild-Moderate_progression_d12-25-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD8_c01-LEF1|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.56e-03 | 161 | 21 | 2 | 5fba13f0aa5002f7eefe219e2c6a07e163f1a50d | |
| ToppCell | facs-Lung-nan-3m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-03 | 162 | 21 | 2 | 3fd6aaf0fbaffc7ab38aa25e46c37ef511e1e704 | |
| ToppCell | facs-Lung-nan-3m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-03 | 162 | 21 | 2 | 8134f73eb76693f4f1845f643042fdc1e81c274c | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-03 | 162 | 21 | 2 | 484ea4ac40de672dcbd2583a52cb7f385c918814 | |
| ToppCell | facs-Lung-EPCAM-18m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.59e-03 | 162 | 21 | 2 | bba144ac5332bab9eba2ccf599703c781a7f88f1 | |
| ToppCell | E16.5-Immune-Immune_Myeloid-Monocytic-Macrophage-iMON-iMON_G2M|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.59e-03 | 162 | 21 | 2 | 9d6931619f5eb847c79d00ff5ae031fef30fd55c | |
| ToppCell | TCGA-Adrenal-Primary_Tumor-Adrenocortical_carcinoma-Usual_Type-6|TCGA-Adrenal / Sample_Type by Project: Shred V9 | 2.59e-03 | 162 | 21 | 2 | 0e8fb83acb8ea9905cc3ca985feb8a00931549ff | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-03 | 163 | 21 | 2 | 8dc0128eeede933537e3bcc5d6ec0322711552f3 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-non-classical_monocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.62e-03 | 163 | 21 | 2 | f6c8db5963ee1f8e0c2996f1aeecd58c00e9b099 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-AT_2-AT1_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.62e-03 | 163 | 21 | 2 | fd35f1237c23367753ac2bc3e893f0e3c714129c | |
| ToppCell | droplet-Liver-Hepatocytes-24m-Myeloid-Kupffer_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-03 | 163 | 21 | 2 | fd243ca223079033be480a24817a399f281fa4d4 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Lymphocytic-T_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-03 | 163 | 21 | 2 | 8028636632c168dc50731d0ebecaf88a70daf81d | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-03 | 163 | 21 | 2 | 953a7db7e90a913e81002d2141fbbd5f1fdf2197 | |
| ToppCell | droplet-Lung-3m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.65e-03 | 164 | 21 | 2 | ea2897942ad72fba900c7ab354d6a9e203bf0e4a | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-Nonclassical_Monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-03 | 164 | 21 | 2 | 15d52666e5150e7c34b1f641a937fb2d5e8aaf8a | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-non-classical_monocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.65e-03 | 164 | 21 | 2 | d622f0d8d8bad48dfdf160ec63c545df192637a9 | |
| ToppCell | facs-Lung-3m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.65e-03 | 164 | 21 | 2 | 11dfd84f5fb90de330858e1e852848832734e004 | |
| ToppCell | droplet-Heart-4Chambers-18m-Myeloid-cardiac_mast_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-03 | 165 | 21 | 2 | a761e0a36d5da8fec916d684f81e60f5590fd9ee | |
| ToppCell | droplet-Heart-4Chambers-18m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-03 | 165 | 21 | 2 | af423307af484661284793a08091777d998e6fba | |
| ToppCell | droplet-Heart-4Chambers-18m-Myeloid-mast_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.68e-03 | 165 | 21 | 2 | 680bdd150bc0a4e50244e57b1226a9b06a6bdbc9 | |
| ToppCell | 356C-Lymphocytic-CD8+_Cytotoxic_T-cell-CD8+_Cytotoxic_T_cell_6|356C / Donor, Lineage, Cell class and subclass (all cells) | 2.71e-03 | 166 | 21 | 2 | c4f7ea1cad962b1d6ad77423d15978b68a0d6f1d | |
| ToppCell | droplet-Spleen-nan-18m-Hematologic-nan|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-03 | 166 | 21 | 2 | e841e62cb20235d6233f78f4155fb8c0ffb1ef1b | |
| ToppCell | droplet-Spleen-nan-18m-Hematologic|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-03 | 166 | 21 | 2 | 3ca3ddb663644f0e7f70f9b75833bb54cd9191d3 | |
| ToppCell | 343B-Myeloid-Mast_cell-|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.71e-03 | 166 | 21 | 2 | 4e47e7f3019fb2dcbc35b4e9b47ee265a97cec5c | |
| ToppCell | 343B-Myeloid-Mast_cell|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 2.71e-03 | 166 | 21 | 2 | f6e2ec767c022982ef416fadb998a7b6b958f76a | |
| ToppCell | droplet-Spleen-nan-18m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.71e-03 | 166 | 21 | 2 | f751cbd01d4978ded7755874ab60504f6291afd7 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-intermediate_monocyte-intermediate_monocyte_l4|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.71e-03 | 166 | 21 | 2 | 1a3a15d1fc76bb91d832cdc6e3da0a6140b94b75 | |
| ToppCell | Control-Lymphocytic_B|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.75e-03 | 167 | 21 | 2 | 956da82394fd6a9f45fc2031796f12cc889542cd | |
| ToppCell | PCW_05-06-Epithelial-Epithelial_alveolar-distal-epi_SFTPC^high_distal_(9)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.75e-03 | 167 | 21 | 2 | 25af48c640e67848594f5902867ba325fc105da4 | |
| ToppCell | Control-Lymphocytic_B-B_cells-B-cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.75e-03 | 167 | 21 | 2 | 69ed8a4a507190a1a66c4baf1f3e9be21ada39d8 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Myeloid-TAM-MG|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.75e-03 | 167 | 21 | 2 | 942134bbabe9972fae80cbc4ed4e94da52f55dc3 | |
| ToppCell | Control-Lymphocytic_B-B_cells|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.75e-03 | 167 | 21 | 2 | a15a70d3837b31cc83a2a9e3f1bbfd77a95f2312 | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 2.75e-03 | 167 | 21 | 2 | ced6ed9b412739c6ced622523347c10295edbf53 | |
| ToppCell | droplet-Lung-30m-Hematologic-myeloid-non-classical_monocyte-nonclassical_monocyte_l4|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.78e-03 | 168 | 21 | 2 | d823979335ac6b5d1f062ebb741c759d2f919dbf | |
| ToppCell | droplet-Spleen-SPLEEN-1m-Hematologic-proerythroblast|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-03 | 168 | 21 | 2 | f3b7a7df54988de77dcc7066e2fc1feb9c280b13 | |
| Drug | nitazoxanide | 2.63e-05 | 9 | 20 | 2 | ctd:C041747 | |
| Drug | I-hu | 4.01e-05 | 11 | 20 | 2 | CID009547901 | |
| Drug | CL-387,785 | 1.38e-04 | 20 | 20 | 2 | CID000002776 | |
| Drug | estradiol-17 beta-glucuronide | 1.68e-04 | 22 | 20 | 2 | ctd:C025483 | |
| Drug | 2-amino-2-methyl-1-propanol | 2.09e-04 | 346 | 20 | 4 | ctd:C006551 | |
| Drug | 9-NC | 3.81e-04 | 33 | 20 | 2 | CID000123613 | |
| Drug | AC1LBSPF | 4.04e-04 | 34 | 20 | 2 | CID000541529 | |
| Drug | 1uy8 | 4.54e-04 | 36 | 20 | 2 | CID005289228 | |
| Drug | laulimalide | 5.06e-04 | 38 | 20 | 2 | CID006918457 | |
| Drug | indium trichloride | 5.89e-04 | 41 | 20 | 2 | ctd:C020758 | |
| Drug | Testosterone propionate [57-85-2]; Down 200; 11.6uM; MCF7; HT_HG-U133A | 6.33e-04 | 195 | 20 | 3 | 2649_DN | |
| Drug | Hydrochlorothiazide [58-93-5]; Up 200; 13.4uM; MCF7; HT_HG-U133A | 6.43e-04 | 196 | 20 | 3 | 1487_UP | |
| Drug | Praziquantel [55268-74-1]; Down 200; 12.8uM; MCF7; HT_HG-U133A | 6.43e-04 | 196 | 20 | 3 | 7228_DN | |
| Drug | Succinylsulfathiazole [116-43-8]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 6.52e-04 | 197 | 20 | 3 | 2821_UP | |
| Drug | Xylazine [7361-61-7]; Down 200; 18.2uM; HL60; HT_HG-U133A | 6.72e-04 | 199 | 20 | 3 | 2132_DN | |
| Drug | zileuton | 7.74e-04 | 47 | 20 | 2 | ctd:C063449 | |
| Drug | Adenosine Diphosphate | 9.11e-04 | 51 | 20 | 2 | ctd:D000244 | |
| Drug | 8-prenylnaringenin | 9.47e-04 | 52 | 20 | 2 | CID000480764 | |
| Drug | isoxazole | 1.10e-03 | 56 | 20 | 2 | CID000009254 | |
| Drug | Probenecid | 1.22e-03 | 59 | 20 | 2 | ctd:D011339 | |
| Drug | gefitinib | 1.37e-03 | 255 | 20 | 3 | CID000123631 | |
| Drug | coumestrol | 1.66e-03 | 69 | 20 | 2 | CID005281707 | |
| Disease | chromosome 15q11.2 deletion syndrome (implicated_via_orthology) | 1.45e-06 | 3 | 21 | 2 | DOID:0060393 (implicated_via_orthology) | |
| Disease | prostate carcinoma, type 2 diabetes mellitus | 8.05e-04 | 59 | 21 | 2 | EFO_0001663, MONDO_0005148 | |
| Disease | rheumatoid arthritis (is_marker_for) | 1.10e-03 | 69 | 21 | 2 | DOID:7148 (is_marker_for) | |
| Disease | Drug toxicity | 1.62e-03 | 84 | 21 | 2 | C0013221 | |
| Disease | Adverse reaction to drug | 1.62e-03 | 84 | 21 | 2 | C0041755 | |
| Disease | chronic obstructive pulmonary disease (is_marker_for) | 2.16e-03 | 97 | 21 | 2 | DOID:3083 (is_marker_for) | |
| Disease | Acute kidney injury | 2.33e-03 | 101 | 21 | 2 | C2609414 | |
| Disease | Kidney Failure, Acute | 2.33e-03 | 101 | 21 | 2 | C0022660 | |
| Disease | Acute Kidney Insufficiency | 2.33e-03 | 101 | 21 | 2 | C1565662 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| TMYHAKAKDQLTCNK | 1346 | P01024 | |
| KLIQKYKEAMSNKAC | 391 | Q13434 | |
| ADYKSKKNHCKQLKS | 491 | Q16625 | |
| NMKCSVKNDHSAYKR | 176 | Q7L576 | |
| SHLNKTCMKNYESKK | 41 | Q2VYF4 | |
| YAAKKHMKKCSSSLA | 1086 | O00370 | |
| KAKKMATCKYNACHV | 36 | Q9H1H1 | |
| TSFKNNSKEKCSLKH | 566 | Q32MH5 | |
| AAVVTKKKTHKYNCK | 926 | Q8IXT1 | |
| KKTNKSMYECKKSDQ | 331 | Q5T2T1 | |
| NMKCSVKNDHSAYKR | 176 | Q96F07 | |
| INSLSSEMHKKCYKN | 21 | Q4QY38 | |
| KSKMNYARCFHKMIS | 471 | Q96M94 | |
| QNMAEKHTKKKCYTE | 1646 | Q8NF50 | |
| KHTKKKCYTEAAMCL | 1651 | Q8NF50 | |
| KHAQQKLLDSTKMCS | 291 | Q5VVM6 | |
| AMKYIKSNSKNSSHH | 136 | Q7Z4H7 | |
| SLKDYCTRMKENQKH | 476 | P07900 | |
| KTKTYQVAHMKSKDN | 486 | P33527 | |
| CAALTHMYSKNKKVS | 251 | Q6UWF7 | |
| CHSYQESTKQLTMKK | 386 | Q9UPT9 | |
| CMNSHKTKYAKSQSL | 566 | Q9UBW7 | |
| ELYMCHKCKKKQKST | 381 | Q9Y6I4 | |
| CQKTFKTSLNCKKHM | 746 | Q9UL36 | |
| KTSLNCKKHMKTHRY | 751 | Q9UL36 |